Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
Oncogene, Published online: 28 February 2024; doi:10.1038/s41388-024-02990-wCorrection: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions (Source: Oncogene)
Source: Oncogene - February 28, 2024 Category: Cancer & Oncology Authors: C. -R Pradeep A. Zeisel W. J. K östler M. Lauriola J. Jacob-Hirsch B. Haibe-Kains N. Amariglio N. Ben-Chetrit A. Emde I. Solomonov G. Neufeld M. Piccart I. Sagi C. Sotiriou G. Rechavi E. Domany C. Desmedt Y. Yarden Source Type: research
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance
Oncogene, Published online: 28 February 2024; doi:10.1038/s41388-024-02972-yLINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance (Source: Oncogene)
Source: Oncogene - February 28, 2024 Category: Cancer & Oncology Authors: Leiyan Yang Miaomiao Wang Ya Wang Yong Zhu Jiarui Wang Mingming Wu Qianying Guo Xinghua Han Vijay Pandey Zhengsheng Wu Peter E. Lobie Tao Zhu Source Type: research
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Oncogene, Published online: 27 February 2024; doi:10.1038/s41388-024-02986-6Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis (Source: Oncogene)
Source: Oncogene - February 27, 2024 Category: Cancer & Oncology Authors: Antoine Vasseur Luc Cabel Caroline Hego Wissam Takka Olfa Trabelsi Grati Benjamin Renouf Florence Lerebours Delphine Loirat Etienne Brain Paul Cottu Marie-Paule Sablin Jean-Yves Pierga C éline Callens Shufang Renault Fran çois-Clément Bidard Source Type: research
AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis
Oncogene, Published online: 27 February 2024; doi:10.1038/s41388-024-02980-yAF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis (Source: Oncogene)
Source: Oncogene - February 27, 2024 Category: Cancer & Oncology Authors: Babak Oskouian Joanna Y. Lee Shahab Asgharzadeh Ranjha Khan Meng Zhang Julia R. Weisbrod Youn-Jeong Choi Latika Puri Ana E. Aguilar Piming Zhao Julie D. Saba Source Type: research
Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice
Oncogene, Published online: 27 February 2024; doi:10.1038/s41388-024-02984-8Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice (Source: Oncogene)
Source: Oncogene - February 27, 2024 Category: Cancer & Oncology Authors: Peter G. Hendrickson Kristianne M. Oristian MaKenna R. Browne Lixia Luo Yan Ma Diana M. Cardona Joshua O. Nash Pedro L. Ballester Scott Davidson Adam Shlien Corinne M. Linardic David G. Kirsch Source Type: research
Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10
Oncogene, Published online: 26 February 2024; doi:10.1038/s41388-024-02975-9Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10 (Source: Oncogene)
Source: Oncogene - February 26, 2024 Category: Cancer & Oncology Authors: Mahmood H. Dalhat Sharath Narayan Hannah Serio Daniel Arango Source Type: research
Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma
Oncogene, Published online: 26 February 2024; doi:10.1038/s41388-024-02985-7Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma (Source: Oncogene)
Source: Oncogene - February 26, 2024 Category: Cancer & Oncology Authors: Tao Zhang Fei Su Bofang Wang Lixin Liu Yongbin Lu Hongxin Su Ruijiang Ling Peng Yue Huanyu Dai Tianning Yang Jingru Yang Rui Chen Ruiyue Wu Kaili Zhu Da Zhao Xiaoming Hou Source Type: research
Robustness of cancer microbiome signals over a broad range of methodological variation
Oncogene, Published online: 23 February 2024; doi:10.1038/s41388-024-02974-wRobustness of cancer microbiome signals over a broad range of methodological variation (Source: Oncogene)
Source: Oncogene - February 23, 2024 Category: Cancer & Oncology Authors: Gregory D. Sepich-Poore Daniel McDonald Evguenia Kopylova Caitlin Guccione Qiyun Zhu George Austin Carolina Carpenter Serena Fraraccio Stephen Wandro Tomasz Kosciolek Stefan Janssen Jessica L. Metcalf Se Jin Song Jad Kanbar Sandrine Miller-Montgomery Robe Source Type: research
miR-147b mediated suppression of DUSP8 promotes lung cancer progression
Oncogene, Published online: 23 February 2024; doi:10.1038/s41388-024-02969-7miR-147b mediated suppression of DUSP8 promotes lung cancer progression (Source: Oncogene)
Source: Oncogene - February 23, 2024 Category: Cancer & Oncology Authors: Kati Turkowski Frederik Herzberg Stefan G ünther Andreas Weigert Tamara Haselbauer Ludger Fink David Brunn Friedrich Grimminger Werner Seeger Holger S ültmann Thorsten Stiewe Soni S. Pullamsetti Rajkumar Savai Source Type: research
O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation
Oncogene, Published online: 23 February 2024; doi:10.1038/s41388-024-02977-7O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation (Source: Oncogene)
Source: Oncogene - February 23, 2024 Category: Cancer & Oncology Authors: Zhongqi Feng Jiaxin Yin Zhirong Zhang Zhen Chen Luyi Huang Ni Tang Kai Wang Source Type: research
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
Oncogene, Published online: 23 February 2024; doi:10.1038/s41388-024-02983-9Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer (Source: Oncogene)
Source: Oncogene - February 23, 2024 Category: Cancer & Oncology Authors: X. Q. Zheng J. P. Guo H. Yang M. Kanai L. L. He Y. Y. Li J. M. Koomen S. Minton M. Gao X. B. Ren D. Coppola J. Q. Cheng Source Type: research
Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
Oncogene, Published online: 23 February 2024; doi:10.1038/s41388-024-02964-yRetraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin (Source: Oncogene)
Source: Oncogene - February 23, 2024 Category: Cancer & Oncology Authors: L. Damiano K. M. Stewart N. Cohet J. K. Mouw J. N. Lakins J. Debnath D. Reisman J. A. Nickerson A. N. Imbalzano V. M. Weaver Source Type: research
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
Oncogene, Published online: 22 February 2024; doi:10.1038/s41388-024-02973-xCancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence (Source: Oncogene)
Source: Oncogene - February 22, 2024 Category: Cancer & Oncology Authors: Steven E. Reid Jessica Pantaleo Paulina Bolivar Matteo Bocci Jonas Sj ölund Mikkel Morsing Eugenia Cordero Sara Larsson Maria Malmberg Brinton Seashore-Ludlow Kristian Pietras Source Type: research
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients
Oncogene, Published online: 22 February 2024; doi:10.1038/s41388-024-02981-xLoss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients (Source: Oncogene)
Source: Oncogene - February 22, 2024 Category: Cancer & Oncology Authors: Sara Meril Maya Muhlbauer Avni Chen Lior Marcela Bahlsen Tsviya Olender Alon Savidor Judit Krausz Hila Belhanes Peled Hila Birisi Nofar David Shani Bialik Ruth Scherz-Shouval Yehuda Ben David Adi Kimchi Source Type: research
The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK
Oncogene, Published online: 21 February 2024; doi:10.1038/s41388-024-02966-wThe BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK (Source: Oncogene)
Source: Oncogene - February 21, 2024 Category: Cancer & Oncology Authors: Hiroki Sato Tatsuo Ito Takuo Hayashi Shigehisa Kitano Hediye Erdjument-Bromage Matthew J. Bott Shinichi Toyooka Marjorie Zauderer Marc Ladanyi Source Type: research
